Subconjunctival carboplatin in retinoblastoma: Impact of tumor burden and dose schedule

Archives of Ophthalmology

Volumn 118, Issue 11, 2000, Pages 1549-1554

  Hayden, Brandy H ^a   Murray, Timothy G ^a   Scott, Ingrid U ^a   Cicciarelli, Nicole ^a   Hernandez, Eleut ^a   Feuer, William ^a   Fulton, Lilia ^b   O'Brien, Joan M ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINOBLASTOMA; TREATMENT OUTCOME;

EID: 0033769554     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.11.1549     Document Type: Article

References (52)

1. A prospective study on the treatment of retinoblastoma in 72 patients
2. Retinoblastoma: Correlation between age at diagnosis and survival
3. Retinoblastoma
4. Changing concepts in the management of retinoblastoma
5. Current approaches to the diagnosis and management of retinoblastoma
6. Orbital recurrence of retinoblastoma successfully treated by combined therapy
7. Analysis of treatment results in 36 children with retinoblastoma treated by scleral plaque irradiation
8. Proton beam irradiation for treatment of experimental human retinoblastoma
9. Prediction of the risk of hereditary retinoblastoma using DNA polymorphisms within the retinoblastoma gene
10. Second nonocular tumors in survivors of heritable retinoblastoma
11. Incidence of second neoplasms in patients with bilateral retinoblastoma
12. Cancer incidence after retinoblastoma: Radiation dose and sarcoma risk
13. Second nonocular tumors in survivors of bilateral retinoblastoma: A possible age effect on radiation-related risk
14. Mortality from second tumors among long-term survivors of retinoblastoma
15. Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma
16. The role of radiation therapy in retinoblastoma
17. Bone sarcomas as second malignant neoplasms following childhood cancer
18. Bone tumors other than osteosarcoma after retinoblastoma
19. Second non-ocular tumors in retinoblastoma survivors: Are they radiation induced?
20. Retinoblastoma: The case for radiotherapy and for adjuvant chemotherapy
21. Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma
22. The role of chemotherapy in orbital involvement of retinoblastoma: The experience of a single institution with 33 patients
23. Chemotherapy in retinoblastoma: Current status and future directions
24. Chemotherapy for retinoblastoma: Where do we go from here? A review of published literature and meeting abstracts, including discussions during the Vth International Symposium on Retinoblastoma, October 1990
25. Platinum complexes in cancer medicine: Pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity
26. Acute non-lymphocytic leukemia following multimodality therapy for retinoblastoma
27. What is the place of carboplatin in paediatric oncology?
28. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors
29. New chemotherapy and focal therapy for intraocular retinoblastoma
30. Chemoreduction in the initial management of intraocular retinoblastoma
31. Intraocular concentrations of chemotherapeutic agents after systemic or local administration
32. Bone sarcomas linked to radiotherapy and chemotherapy in children
33. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma
34. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma
35. Local carboplatin therapy in transgenic murine retinoblastoma
36. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line
37. Retinoblastoma in transgenic mice
38. Trilateral retinoblastoma in transgenic mice
39. A transgenic mouse model for trilateral retinoblastoma
40. Trilateral retinoblastoma: Insights into histogenesis and management
41. Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma
42. Retinoblastoma: A review emphasizing genetics of management strategies
43. The role of chemotherapy in the treatment of retinoblastoma
44. Emerging chemotherapeutic strategies in the management of intraocular retinoblastoma
45. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma
46. The effect of chemoreduction on retinoblastoma-induced retinal detachment
47. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy
48. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein
49. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma
50. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma